AzTrials
AzTrials

Coronary Artery DiseasePRV-KORONCT02404948

PRV-based Detection of CAD in Comparison to Standard Methods

An observational study of Coronary Artery Disease, run by University Medicine Greifswald at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a validation study comparing a pulse wave based algorithm for the detection of coronary artery disease with parameters from coronary angiography, echocardiography and cardiogoniometry. Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Coronary Artery Disease
What is being tested?
Diagnostic algorithm
How many people
156 participants
Where
1 siteGermany
Study dates
Apr 2015to Jun 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Subjects referred to first coronary angiography due to suspected CAD

Who may be able to join

  • Coronary angiography indication present
  • informed written consent

Who cannot join

  • Previous coronary angiography
  • Known CAD (history of coronary angioplasty, stent implantation and/or bypass surgery)
  • atrial fibrillation (at time of measurement)
  • severe ventricular extrasystole (e.g. >=10% ventricular extrasystoles, bigemina)
  • pregnancy, lactation

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Marcus Dörr

    Greifswald, 17475

Other trials in Germany

About this study

Official title: Comparison of a Pulse Wave Based Approach for Detection of Coronary Artery Disease Compared to Standard Methods

This is a validation study comparing a pulse wave based algorithm for the detection of coronary artery disease with parameters from coronary angiography, echocardiography and cardiogoniometry.

Read the detailed description

The study will validate a pulse wave based algorithm for the detection of coronary artery disease (CAD) with parameters from standard methods. Subjects will be patients admitted to coronary angiography due to suspected CAD. Pulse wave signals will be analyzed according to novelly established algorithm regarding the presence of CAD and/or myocardial ischemia. These results be compared to the diagnoses made by coronary angiography (primary endpoint): presence of minimum one coronary artery stenose >=50%. For secondary analyses, results will be compared to parameters form echocardiography and cardiogoniometry.

Being tested
Diagnostic algorithm
Keywords
coronary artery disease, diagnosis, non-invasive
Medical subject headings
Coronary Artery Disease, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diagnostic algorithmOther

    Validation of a diagnostic algorithm used to detect coronary artery disease and/or myocardial ischemia based on pulse wave analyses.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence of CAD - angio (minimum 1 stenosis >=50%)

    Presence of CAD in coronary angiography: minimum 1 stenosis >=50%

    Measured: 1 day

Secondary outcomes (5)
  1. Presence of CAD number - angio (Number of coronary vessels with at least 1 stenosis >=50% in coronary angiography)

    Number of coronary vessels with at least 1 stenosis >=50% in coronary angiography

    Measured: 1 day

  2. Wall motion abnormality - echo (Presence of wall motion abnormality in at least 1 segment (2D echocardiography)

    Presence of wall motion abnormality in at least 1 segment (2D echocardiography)

    Measured: 1 day

  3. Wall motion index - echo (Wall motion index (2D and 3D echocardiography)

    Wall motion index (2D and 3D echocardiography)

    Measured: 1 day

  4. Global longitudinal strain (2D and 3D echocardiography)

    Global longitudinal strain (2D and 3D echocardiography)

    Measured: 1 day

  5. Abnormal cardiogoniometry

    Abnormal results of cardiogoniometry

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2015 (estimated)
  2. Study startApr 2015
  3. Primary completionJul 2016
  4. Study completionJun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
156 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02404948
Sponsor's protocol ID
PRV-Koro-Study-001
Acronym
PRV-KORO
Status last verified
Jun 2018
First submitted
23 Mar 2015
Last updated
3 Jul 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Coronary Artery Disease, run by University Medicine Greifswald at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence of CAD - angio (minimum 1 stenosis >=50%) (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in